Operator: Good day, and welcome to the Kymera Therapeutics First Quarter 2024 Results Conference Call. All participants will be in the listen-only mode.
By Colin Kellaher Akero Therapeutics shares lost two-thirds of their value and fell to a 52-week low on Tuesday after the biotechnology company said a Phase.
Operator: Good afternoon and welcome to the Trevi Therapeutics Q4 and Year-End 2022 Earnings Conference Call. Please note this event is being recorded.
Eledon Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ELDN) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Paul Little – Chief Financial Officer David-Alexandre Gros –.